pmc logo image
Logo of envhperEHP WebsiteAbout EHPPublicationsNews By TopicAuthorsSubscribePressEmail AlertsSearch EHP

Formats:

Environ Health Perspect. 1994 October; 102(Suppl 5): 19–23.
PMCID: PMC1567260
Research Article
Cellular and molecular mechanisms of asbestos carcinogenicity: implications for biopersistence.
J C Barrett
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.
Abstract
Carcinogenic agents can influence the carcinogenic process either by mutating critical target genes or by increasing the number of cells at risk for mutations. Cytogenetic and molecular studies of asbestos-related cancers indicate that inactivation or loss of multiple tumor suppressor genes occurs during lung cancer development. Aneuploidy and other chromosomal changes induced by asbestos fibers may be involved in genetic alterations in asbestos-related cancers. Furthermore, asbestos fibers may influence the carcinogenic process by inducing cell proliferation, free radicals, or other promotional mechanisms. Therefore, asbestos fibers may act at multiple stages of the carcinogenic process by both genetic and epigenetic mechanisms. Biopersistence is undoubtedly important in fiber carcinogenicity. However, the time required for a fiber to remain in the lung to exert a cancer-related effect is difficult to specify.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (823K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Barrett JC. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect. 1993 Apr;100:9–20. [PubMed]
  • Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. [PubMed]
  • Bishop JM. Molecular themes in oncogenesis. Cell. 1991 Jan 25;64(2):235–248. [PubMed]
  • Nowell PC. The clonal evolution of tumor cell populations. Science. 1976 Oct 1;194(4260):23–28. [PubMed]
  • Walker C, Everitt J, Barrett JC. Possible cellular and molecular mechanisms for asbestos carcinogenicity. Am J Ind Med. 1992;21(2):253–273. [PubMed]
  • Olofsson K, Mark J. Specificity of asbestos-induced chromosomal aberrations in short-term cultured human mesothelial cells. Cancer Genet Cytogenet. 1989 Aug;41(1):33–39. [PubMed]
  • Flejter WL, Li FP, Antman KH, Testa JR. Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes. Genes Chromosomes Cancer. 1989 Nov;1(2):148–154. [PubMed]
  • Gibas Z, Li FP, Antman KH, Bernal S, Stahel R, Sandberg AA. Chromosome changes in malignant mesothelioma. Cancer Genet Cytogenet. 1986 Feb 15;20(3-4):191–201. [PubMed]
  • Popescu NC, Chahinian AP, DiPaolo JA. Nonrandom chromosome alterations in human malignant mesothelioma. Cancer Res. 1988 Jan 1;48(1):142–147. [PubMed]
  • Bello MJ, Rey JA, Avilés MJ, Arevalo M, Benítez J. Cytogenetic findings in an effusion secondary from pleural mesothelioma. Cancer Genet Cytogenet. 1987 Nov;29(1):75–79. [PubMed]
  • Tiainen M, Tammilehto L, Mattson K, Knuutila S. Nonrandom chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet Cytogenet. 1988 Jul 15;33(2):251–274. [PubMed]
  • Mark J. Monosomy 14, monosomy 22 and 13q--three chromosomal abnormalities observed in cells of two malignant mesotheliomas studied by banding techniques. Acta Cytol. 1978 Sep–Oct;22(5):398–401. [PubMed]
  • Versnel MA, Bouts MJ, Hoogsteden HC, van der Kwast TH, Delahaye M, Hagemeijer A. Establishment of human malignant mesothelioma cell lines. Int J Cancer. 1989 Aug 15;44(2):256–260. [PubMed]
  • Pelin-Enlund K, Husgafvel-Pursiainen K, Tammilehto L, Klockars M, Jantunen K, Gerwin BI, Harris CC, Tuomi T, Vanhala E, Mattson K, et al. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis. 1990 Apr;11(4):673–681. [PubMed]
  • Sugawara O, Oshimura M, Koi M, Annab LA, Barrett JC. Induction of cellular senescence in immortalized cells by human chromosome 1. Science. 1990 Feb 9;247(4943):707–710. [PubMed]
  • Stenman G, Olofsson K, Månsson T, Hagmar B, Mark J. Chromosomes and chromosomal evolution in human mesotheliomas as reflected in sequential analyses of two cases. Hereditas. 1986;105(2):233–239. [PubMed]
  • Zbar B. Chromosomal deletions in lung cancer and renal cancer. Important Adv Oncol. 1989:41–60. [PubMed]
  • Yokota J, Tsukada Y, Nakajima T, Gotoh M, Shimosato Y, Mori N, Tsunokawa Y, Sugimura T, Terada M. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res. 1989 Jul 1;49(13):3598–3601. [PubMed]
  • Carpenter G. Properties of the receptor for epidermal growth factor. Cell. 1984 Jun;37(2):357–358. [PubMed]
  • Trent JM, Leong SP, Meyskens FL. Chromosome alterations in human malignant melanoma. Carcinog Compr Surv. 1989;11:165–186. [PubMed]
  • Betsholtz C, Johnsson A, Heldin CH, Westermark B, Lind P, Urdea MS, Eddy R, Shows TB, Philpott K, Mellor AL, et al. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature. 1986 Apr 24;320(6064):695–699. [PubMed]
  • Meloni AM, Stephenson CF, Li FP, Sandberg AA. del(6q) as a possible primary change in malignant mesothelioma. Cancer Genet Cytogenet. 1992 Mar;59(1):57–61. [PubMed]
  • Jaurand MC. Particulate-state carcinogenesis: a survey of recent studies on the mechanisms of action of fibres. IARC Sci Publ. 1989;(90):54–73. [PubMed]
  • Hesterberg TW, Barrett JC. Induction by asbestos fibers of anaphase abnormalities: mechanism for aneuploidy induction and possibly carcinogenesis. Carcinogenesis. 1985 Mar;6(3):473–475. [PubMed]
  • Hesterberg TW, Butterick CJ, Oshimura M, Brody AR, Barrett JC. Role of phagocytosis in Syrian hamster cell transformation and cytogenetic effects induced by asbestos and short and long glass fibers. Cancer Res. 1986 Nov;46(11):5795–5802. [PubMed]
  • Wang NS, Jaurand MC, Magne L, Kheuang L, Pinchon MC, Bignon J. The interactions between asbestos fibers and metaphase chromosomes of rat pleural mesothelial cells in culture. A scanning and transmission electron microscopic study. Am J Pathol. 1987 Feb;126(2):343–349. [PubMed]
  • Hesterberg TW, Barrett JC. Dependence of asbestos- and mineral dust-induced transformation of mammalian cells in culture on fiber dimension. Cancer Res. 1984 May;44(5):2170–2180. [PubMed]
  • Oshimura M, Hesterberg TW, Tsutsui T, Barrett JC. Correlation of asbestos-induced cytogenetic effects with cell transformation of Syrian hamster embryo cells in culture. Cancer Res. 1984 Nov;44(11):5017–5022. [PubMed]
  • Klominek J, Robért KH, Hjerpe A, Wickström B, Gahrton G. Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res. 1989 Nov 1;49(21):6118–6122. [PubMed]
  • Lechner JF, Tokiwa T, LaVeck M, Benedict WF, Banks-Schlegel S, Yeager H, Jr, Banerjee A, Harris CC. Asbestos-associated chromosomal changes in human mesothelial cells. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3884–3888. [PubMed]
  • Ke Y, Reddel RR, Gerwin BI, Reddel HK, Somers AN, McMenamin MG, LaVeck MA, Stahel RA, Lechner JF, Harris CC. Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. Am J Pathol. 1989 May;134(5):979–991. [PubMed]
  • Decker HJ, Li FP, Bixenman HA, Sandberg AA. Chromosome 3 and 12p rearranged in a well-differentiated peritoneal mesothelioma. Cancer Genet Cytogenet. 1990 May;46(1):135–137. [PubMed]